Cargando…
Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation
BACKGROUND AND PURPOSE: It is unknown what the optimal anticoagulant level is to prevent thromboembolic stroke in patients with left ventricular assist device (LVAD) support. We aimed to evaluate the relation between coagulation status and the occurrence of thromboembolic stroke in HeartMate-II LVAD...
Autores principales: | van den Bergh, Walter M., Lansink-Hartgring, Annemieke Oude, van Duijn, Abram L., Engström, Annemarie E., Lahpor, Jaap R., Slooter, Arjen JC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606546/ https://www.ncbi.nlm.nih.gov/pubmed/26471178 http://dx.doi.org/10.1186/s13019-015-0333-7 |
Ejemplares similares
-
Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation
por: Damman, Kevin, et al.
Publicado: (2022) -
Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
por: Elasfar, Abdelfatah, et al.
Publicado: (2018) -
Successful Pediatric Mechanical Thrombectomy for HeartMate
3-Related Intracranial Thromboembolism
por: Proulx, Catherine, et al.
Publicado: (2022) -
Long-Term Withdrawal of Anticoagulation and Antiplatelet Therapy in a HeartMate 3 Left Ventricular Assist Device
por: Menchaca, Kristina, et al.
Publicado: (2022) -
Changes in Red Blood Cell Properties and Platelet Function during Extracorporeal Membrane Oxygenation
por: Lansink-Hartgring, Annemieke Oude, et al.
Publicado: (2020)